Association between executive dysfunction and hippocampal volume in Alzheimer's disease

Int Psychogeriatr. 2011 Jun;23(5):764-71. doi: 10.1017/S1041610210002164. Epub 2010 Nov 25.

Abstract

Background: Some previous research has hypothesized that executive dysfunction in patients with early Alzheimer's disease (AD) occurs as a result of a disconnection between different cerebral areas. The aim of the present study was to evaluate how the hippocampal volume influences executive function as a non-memory cognitive function.

Methods: From 157 consecutive patients with AD or amnestic mild cognitive impairment (A-MCI), we recruited 107 subjects who had a global Clinical Dementia Rating (CDR) of 0.5 or 1.0 and whose degree of hippocampal atrophy had been measured using magnetic resonance imaging (MRI); the severity of atrophy was assessed using the voxel-based specific regional analysis for Alzheimer's disease (VSRAD) system. We divided the subjects into three groups: mild atrophy, 0 < Z-score < 1.0 (N = 21); moderate atrophy, 1.0 ≤ Z-score < 2.0 (N = 46); or severe atrophy, 2.0 ≤ Z-score < 4.0 (N = 40) according to the Z-score and compared the Frontal Assessment Battery (FAB) and its subtest scores between each atrophy group.

Results: The results demonstrated that age, sex ratio, duration of illness, education years, MMSE score, Behave-AD score, and proportion of atrophy area in total brain (%) were not significantly different among the three groups. Only the go/no-go score among the six subtests was significantly lower for increasing atrophy severity (P < 0.05). Furthermore, hippocampal atrophy significantly influenced the go/no-go score independently of interactions from whether the diagnosis was early AD or A-MCI (P < 0.05).

Conclusion: These results support a significant association between hippocampal atrophy and executive dysfunction as a non-memory cognitive impairment in patients with early AD and A-MCI.

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / epidemiology
  • Alzheimer Disease* / etiology
  • Atrophy / pathology
  • Cognitive Dysfunction* / complications
  • Cognitive Dysfunction* / pathology
  • Cognitive Dysfunction* / psychology
  • Executive Function / physiology*
  • Female
  • Hippocampus / pathology*
  • Humans
  • Japan
  • Magnetic Resonance Imaging / methods
  • Male
  • Mental Competency*
  • Mental Recall / physiology
  • Neuropsychological Tests
  • Organ Size
  • Psychiatric Status Rating Scales
  • Risk Factors
  • Severity of Illness Index